Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec;30(12):1279-1295.
doi: 10.1177/0269881116678781. Epub 2016 Nov 17.

The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms

Affiliations

The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms

Frederick S Barrett et al. J Psychopharmacol. 2016 Dec.

Abstract

Acute adverse psychological reactions to classic hallucinogens ("bad trips" or "challenging experiences"), while usually benign with proper screening, preparation, and support in controlled settings, remain a safety concern in uncontrolled settings (such as illicit use contexts). Anecdotal and case reports suggest potential adverse acute symptoms including affective (panic, depressed mood), cognitive (confusion, feelings of losing sanity), and somatic (nausea, heart palpitation) symptoms. Responses to items from several hallucinogen-sensitive questionnaires (Hallucinogen Rating Scale, the States of Consciousness Questionnaire, and the Five-Dimensional Altered States of Consciousness questionnaire) in an Internet survey of challenging experiences with the classic hallucinogen psilocybin were used to construct and validate a Challenging Experience Questionnaire. The stand-alone Challenging Experience Questionnaire was then validated in a separate sample. Seven Challenging Experience Questionnaire factors (grief, fear, death, insanity, isolation, physical distress, and paranoia) provide a phenomenological profile of challenging aspects of experiences with psilocybin. Factor scores were associated with difficulty, meaningfulness, spiritual significance, and change in well-being attributed to the challenging experiences. The factor structure did not differ based on gender or prior struggle with anxiety or depression. The Challenging Experience Questionnaire provides a basis for future investigation of predictors and outcomes of challenging experiences with classic hallucinogens.

Keywords: Psilocybin; challenging experiences; factor analysis; psychedelics; scale development.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting of Interests

RRG is a member of the Board of Directors of the Heffter Research Institute.

References

    1. Abramson HA. Lysergic acid diethylamide (LSD-25). XXXI. comparison by questionnaire of psychotomimetic activity of congeners on normal subjects and drug addicts. The Journal of Mental Science. 1960;106:1120–1123. - PubMed
    1. Barrett FS, Johnson MW, Griffiths RR. Validation of the revised mystical experience questionnaire in experimental sessions with psilocybin. Journal of Psychopharmacology (Oxford, England) 2015;29(11):1182–1190. doi: 10.1177/0269881115609019. - DOI - PMC - PubMed
    1. Belleville RE. MMPI score changes induced by lysergic acid diethylamide (LSD-25) Journal of Clinical Psychology. 1956;12(3):279–282. - PubMed
    1. Bentler PM. Comparative fit indexes in structural models. Psychological Bulletin. 1990;107(2):238–246. - PubMed
    1. Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PC, Strassman RJ. Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study. Journal of Psychopharmacology (Oxford, England) 2015;29(3):289–299. doi: 10.1177/0269881114565144. - DOI - PubMed

Publication types